Preliminary fatty liver disease grading using general-purpose online large language models: ChatGPT-4 or Bard?

被引:10
作者
Zhang, Yiwen [1 ]
Liu, Hanyun [2 ]
Sheng, Bin [3 ]
Tham, Yih Chung [4 ]
Ji, Hongwei [5 ,6 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Endocrinol & Metab Hepatol, Qingdao, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Dept Infect Dis & Hepatol, Qingdao, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai, Peoples R China
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[5] Tsinghua Univ, Tsinghua Med, Beijing, Peoples R China
[6] Beijing Tsinghua Changgung Hosp, Dept Internal Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.jhep.2023.11.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:e279 / e281
页数:3
相关论文
共 10 条
[1]  
ChatGPT. ChatGPT, 2023, Release Notes
[2]   Global burden of liver disease: 2023 update [J].
Devarbhavi, Harshad ;
Asrani, Sumeet K. ;
Arab, Juan Pablo ;
Nartey, Yvonne Ayerki ;
Pose, Elisa ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2023, 79 (02) :516-537
[3]  
Ikura Y, Nonalcoholic fatty Liver disease/nonalcoholic steatohepatitis (NASH)
[4]   Artificial Intelligence in Low- and Middle-Income Countries: Innovating Global Health Radiology [J].
Mollura, Daniel J. ;
Culp, Melissa P. ;
Pollack, Erica ;
Battino, Gillian ;
Scheel, John R. ;
Mango, Victoria L. ;
Elahi, Ameena ;
Schweitzer, Alan ;
Dako, Farouk .
RADIOLOGY, 2020, 297 (03) :513-520
[5]  
OpenAI, 2023, GPT-4 Technical Report
[6]   Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions [J].
Ratziu, Vlad ;
Hompesch, Marcus ;
Petitjean, Mathieu ;
Serdjebi, Cindy ;
Iyer, Janani S. ;
Parwani, Anil V. ;
Tai, Dean ;
Bugianesi, Elisabetta ;
Cusi, Kenneth ;
Friedman, Scott L. ;
Lawitz, Eric ;
Romero-Gomez, Manuel ;
Schuppan, Detlef ;
Loomba, Rohit ;
Paradis, Valerie ;
Behling, Cynthia ;
Sanyal, Arun J. .
JOURNAL OF HEPATOLOGY, 2024, 80 (02) :335-351
[7]   The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials [J].
Sanyal, Arun J. ;
Harrison, Stephen A. ;
Ratziu, Vlad ;
Abdelmalek, Manal F. ;
Diehl, Anna Mae ;
Caldwell, Stephen ;
Shiffman, Mitchell L. ;
Aguilar Schall, Raul ;
Jia, Catherine ;
McColgan, Bryan ;
Djedjos, C. Stephen ;
McHutchison, John G. ;
Subramanian, G. Mani ;
Myers, Robert P. ;
Younossi, Zobair ;
Muir, Andrew J. ;
Afdhal, Nezam H. ;
Bosch, Jaime ;
Goodman, Zachary .
HEPATOLOGY, 2019, 70 (06) :1913-1927
[8]   Pathology and laboratory medicine in low-income and middle-income countries 2: Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions [J].
Sayed, Shahin ;
Cherniak, William ;
Lawler, Mark ;
Tan, Soo Yong ;
El Sadr, Wafaa ;
Wolf, Nicholas ;
Silkensen, Shannon ;
Brand, Nathan ;
Looi, Lai Meng ;
Pai, Sanjay A. ;
Wilson, Michael L. ;
Milner, Danny ;
Flanigan, John ;
Fleming, Kenneth A. .
LANCET, 2018, 391 (10133) :1939-1952
[9]  
Wu C, arXiv, DOI [arXiv:2310.09909, DOI 10.48550/ARXIV.2310.09909]
[10]   Letter 2 regarding "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma" [J].
Zhang, Yiwen ;
Wu, Liwei ;
Mu, Zepeng ;
Ren, Linlin ;
Chen, Ying ;
Liu, Hanyun ;
Xu, Lili ;
Wang, Yangang ;
Wang, Yaxing ;
Cheng, Susan ;
Tham, Yih Chung ;
Sheng, Bin ;
Wong, Tien Yin ;
Ji, Hongwei .
CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01)